Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer ConsortiumJohan Bjerner, Jan Oldenburg, Hans Lilja et al.|European Urology|2023Cited by 13
Abstract 481: Utility of hCG as a biomarker of treatment response in advanced urothelial cancer: A population based series at Akershus University Hospital, NorwayKatarina Puco, Jan Oldenburg, Johan Bjerner et al.|Cancer Research|2021Cited by 1
Long-term predictive value of serum PSA values obtained in clinical practice – Results from the Norwegian Prostate Cancer Consortium (NPCC)Stefan Carlsson, Jan Oldenburg, Ola Bratt et al.|European Urology|2021Cited by 0